|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/145 | |
| C07K 1/20 | |||
| C07K 1/34 | |||
| G01N 33/68 | |||
| C12N 7/00 |
| (11) | Number of the document | 2435066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10730209.3 |
| Date of filing the European patent application | 2010-05-28 | |
| (97) | Date of publication of the European application | 2012-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2010/001423 |
| Date | 2010-05-28 |
| (87) | Number | WO 2010/136896 |
| Date | 2010-12-02 |
| (30) | Number | Date | Country code |
| 217405 P | 2009-05-29 | US |
| (72) |
DORMITZER, Philip, US
WEN, Yingxia, US
PALMER, Gene, US
RINELLA, Paola, IT
WU, Ping, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ASSAYS FOR INFLUENZA VIRUS HEMAGGLUTININS |
| ASSAYS FOR INFLUENZA VIRUS HEMAGGLUTININS |